Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SRNE > SEC Filings for SRNE > Form 8-K on 15-Oct-2013All Recent SEC Filings

Show all filings for SORRENTO THERAPEUTICS, INC.

Form 8-K for SORRENTO THERAPEUTICS, INC.


15-Oct-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

Sorrento Therapeutics, Inc. (the "Company") previously filed a Current Report on Form 8-K on October 2, 2013 disclosing its entry into a Loan and Security Agreement with Oxford Finance LLC and Silicon Valley Bank (the "Loan Agreement"). The Loan Agreement is attached hereto as Exhibit 10.1.

In addition, the Company previously filed a Current Report on Form 8-K on October 11, 2013 disclosing its merger with Sherrington Pharmaceuticals, Inc. In connection with such merger, attached hereto as Exhibit 2.1 and Exhibit 10.2, respectively, is the Agreement and Plan of Merger and Reorganization among Sorrento Therapeutics, Inc., SP Merger Sub, Inc., Sherrington Pharmaceuticals, Inc., Aceras Biomedical LLC, the stockholders of Sherrington Pharmaceuticals, Inc. and Cooley LLP, solely in its capacity as Escrow Agent dated as of October 9, 2013 and the Registration Rights Agreement by and among Sorrento Therapeutics, Inc. and the stockholders of Sherrington Pharmaceuticals, Inc. dated as of October 9, 2013.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.       Description

 2.1              Agreement and Plan of Merger and Reorganization among Sorrento
                  Therapeutics, Inc., SP Merger Sub, Inc., Sherrington
                  Pharmaceuticals, Inc., Aceras Biomedical LLC, the stockholders of
                  Sherrington Pharmaceuticals, Inc. and Cooley LLP, solely in its
                  capacity as Escrow Agent dated as of October 9, 2013*

10.1              Loan and Security Agreement dated as of September 27, 2013 among
                  Oxford Finance LLC, Silicon Valley Bank, Sorrento Therapeutics,
                  Inc. and IgDraSol, Inc.*

10.2              Registration Rights Agreement by and among Sorrento Therapeutics,
                  Inc. and the stockholders of Sherrington Pharmaceuticals, Inc.
                  dated as of October 9, 2013*

*Sorrento hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement to the U.S. Securities and Exchange Commission upon request.


  Add SRNE to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SRNE - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.